BiotechTube

Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Interaction

Conditions

Drug Interaction

Trial Timeline

Nov 1, 2008 → Nov 1, 2008

NCT ID
NCT00806299

About Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice

Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice is a phase 1 stage product being developed by Johnson & Johnson for Drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT00806299. Target conditions include Drug Interaction.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00806299Phase 1Completed

Competing Products

20 competing products in Drug Interaction

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
40
GP404141 + NplateGEROPHARMPhase 3
69
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
33
EC905 + verapamilAstellas PharmaPhase 1
33
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
33
enzalutamide + rifampinAstellas PharmaPhase 1
33
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
33
CefiderocolShionogiApproved
85
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
33
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
33
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
77
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77
Pyrotinib Maleate + EfavirenzJiangsu Hengrui MedicinePhase 1
33

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85